Lifeward (LFWD) Change in Accured Expenses (2015 - 2026)
Lifeward (LFWD) reported Change in Accured Expenses of $717000.0 for Q1 2026, up 553.8% on a YoY basis from $109667.0 in Q1 2025, and up 277.37% sequentially from $190000.0 in Q4 2025.
Lifeward (LFWD) Change in Accured Expenses (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 12 years of Change in Accured Expenses data on file, last reported at $717000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 553.8% year-over-year to $717000.0; the trailing twelve-month figure through Mar 2026 stood at $985000.0 (up 362.44% YoY), and the FY2025 full-year result was $110000.0, up 173.33% from the prior year.
- Change in Accured Expenses grew to $717000.0 in Q1 2026, from $190000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q4 2024 to a low of -$1.0 million in Q3 2023.
- A 5-year average of $30000.0 and a median of -$40000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 1030.0% in 2023 and soared 553.8% in 2026, its largest moves.
- Tracing LFWD's Change in Accured Expenses over 5 years: stood at $399000.0 in 2022, then jumped by 164.41% to $1.1 million in 2023, then rose by 11.37% to $1.2 million in 2024, then slumped by 83.83% to $190000.0 in 2025, then soared by 277.37% to $717000.0 in 2026.
- Business Quant data shows LFWD's Change in Accured Expenses at $717000.0 in Q1 2026, $190000.0 in Q4 2025, and -$13000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 717,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 717,000.00 |
| Mar 31, 2026 | 717,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | -430,000.00 |
| Sep 30, 2024 | -430,000.00 |
| Jun 30, 2024 | -374,000.00 |
| Jun 30, 2024 | -374,000.00 |
| Mar 31, 2024 | -521,000.00 |
| Mar 31, 2024 | -521,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |